HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Edith A Perez Selected Research

letrozole (Femara)

8/20155-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial.
4/2013Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial.
3/2012Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole.
4/2010Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy.
10/2009Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC.
5/2009Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results.
5/2008Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole.
4/2008Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.
8/2007Letrozole: present and future role in the treatment of breast cancer.
5/2007Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Edith A Perez Research Topics

Disease

164Breast Neoplasms (Breast Cancer)
12/2015 - 01/2002
94Neoplasms (Cancer)
11/2015 - 01/2002
8Disease Progression
03/2013 - 07/2004
6Neoplasm Metastasis (Metastasis)
07/2014 - 06/2002
5Hot Flashes
01/2007 - 03/2002
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2014 - 10/2003
4Osteoporosis
04/2013 - 11/2003
4Leukemia
11/2012 - 01/2003
3Noninfiltrating Intraductal Carcinoma (DCIS)
11/2015 - 01/2013
3Arthralgia (Joint Pain)
08/2015 - 11/2003
3Neutropenia
09/2014 - 12/2007
3Hemorrhage
04/2013 - 11/2003
3Heart Failure
03/2008 - 10/2005
3Second Primary Neoplasms (Neoplasms, Second)
08/2006 - 03/2006
2Headache (Headaches)
12/2015 - 12/2007
2Diarrhea
12/2015 - 04/2013
2Ischemia
08/2015 - 12/2007
2Peripheral Nervous System Diseases (PNS Diseases)
07/2015 - 11/2012
2Obesity
07/2015 - 12/2012
2Ductal Carcinoma
06/2015 - 01/2013
2Metabolic Bone Diseases (Osteopenia)
04/2013 - 04/2010
2Osteonecrosis (Kienbock's Disease)
07/2012 - 08/2006
2Bone Resorption
03/2012 - 08/2006
2Amenorrhea
03/2011 - 06/2010
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
08/2010 - 06/2004
2Hypertension (High Blood Pressure)
10/2008 - 12/2007
2Endometrial Neoplasms (Endometrial Cancer)
01/2007 - 11/2006
1Vomiting
12/2015
1Nausea
12/2015
1Fever (Fevers)
08/2015
1Back Pain (Backache)
08/2015

Drug/Important Bio-Agent (IBA)

44trastuzumab (Herceptin)FDA Link
09/2015 - 06/2002
39Epidermal Growth Factor Receptor (EGF Receptor)IBA
11/2015 - 09/2004
30Paclitaxel (Taxol)FDA LinkGeneric
07/2015 - 05/2002
27Estrogens (Estrogen)FDA Link
07/2015 - 01/2002
25TamoxifenFDA LinkGeneric
11/2015 - 03/2002
23HormonesIBA
11/2015 - 11/2003
23Doxorubicin (Adriamycin)FDA LinkGeneric
07/2015 - 01/2003
22Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2015 - 01/2003
19taxaneIBA
11/2015 - 01/2003
18letrozole (Femara)FDA LinkGeneric
08/2015 - 11/2003
13TaxoidsIBA
02/2011 - 01/2003
12Aromatase InhibitorsIBA
08/2015 - 04/2005
12docetaxel (Taxotere)FDA Link
07/2015 - 01/2003
10capecitabine (Xeloda)FDA Link
12/2015 - 08/2007
10AnthracyclinesIBA
02/2011 - 01/2004
9Aromatase (CYP19)IBA
07/2014 - 04/2005
8zoledronic acid (zoledronate)FDA Link
08/2015 - 08/2006
8lapatinib (GW572016)FDA Link
09/2014 - 03/2008
8Progesterone Receptors (Progesterone Receptor)IBA
07/2014 - 03/2006
7ixabepilone (BMS 247550)FDA Link
07/2015 - 08/2007
7bevacizumabFDA Link
07/2015 - 12/2007
7RNA (Ribonucleic Acid)IBA
01/2015 - 07/2004
7Carboplatin (JM8)FDA LinkGeneric
12/2013 - 10/2003
6ParaffinIBA
11/2015 - 12/2005
6anastrozole (Arimidex)FDA LinkGeneric
07/2015 - 08/2006
6Fluorouracil (Carac)FDA LinkGeneric
01/2010 - 01/2003
5Biological Markers (Surrogate Marker)IBA
10/2014 - 10/2008
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2013 - 12/2007
4B 31IBA
11/2014 - 10/2005
4exemestane (Aromasin)FDA Link
07/2014 - 08/2006
4gemcitabineFDA Link
10/2005 - 06/2002
3Vitamin DFDA LinkGeneric
04/2015 - 03/2009
3Messenger RNA (mRNA)IBA
03/2015 - 04/2012
3Phenobarbital (Luminal)FDA Link
01/2015 - 11/2011
3DNA (Deoxyribonucleic Acid)IBA
04/2013 - 10/2008
3Formaldehyde (Formol)FDA Link
01/2013 - 01/2010
3epothilone B (EPO906)IBA
11/2012 - 02/2010
3albumin-bound paclitaxelFDA Link
03/2009 - 10/2005
3Cytochrome P-450 CYP2D6 (CYP2D6)IBA
09/2008 - 12/2005
3Cisplatin (Platino)FDA LinkGeneric
04/2005 - 01/2003
2Mesylates (Mesylate)IBA
12/2015 - 02/2015
22- (3- amino- 2- hydroxypropyl)hexacosahydro- 3- methoxy- 26- methyl- 20,27- bis(methylene)11,15- 18,21- 24,28- triepoxy- 7,9- ethano- 12,15- methano- 9H,15H- furo(3,2- i)furo(2',3'- 5,6)pyrano(4,3- b)(1,4)dioxacyclopentacosin- 5- (4H)- oneIBA
12/2015 - 02/2015
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2015 - 11/2011
2fulvestrant (Faslodex)FDA Link
09/2015 - 03/2006
2130-nm albumin-bound paclitaxelIBA
07/2015 - 06/2007
2Folic Acid (Vitamin M)FDA LinkGeneric
01/2015 - 01/2015
2Epidermal Growth Factor (EGF)IBA
02/2014 - 09/2013
2Estradiol (Estrace)FDA LinkGeneric
04/2013 - 08/2009
2decitabine (5-aza-2'-deoxycytidine)FDA Link
01/2013 - 10/2012
2Complementary DNA (cDNA)IBA
01/2013 - 07/2004
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
03/2011 - 08/2010
2CalciumIBA
04/2010 - 03/2009
2DNA topoisomerase II alphaIBA
01/2010 - 10/2004
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2009 - 03/2008
2risedronic acid (risedronate)FDA LinkGeneric
03/2009 - 08/2006
2Interleukin-17 (Interleukin 27)IBA
09/2008 - 04/2006
1pertuzumabIBA
09/2015
1CreatinineIBA
08/2015
1CRT 0066101IBA
06/2015

Therapy/Procedure

40Drug Therapy (Chemotherapy)
11/2015 - 01/2003
19Adjuvant Chemotherapy
11/2015 - 01/2003
4Mastectomy (Mammectomy)
04/2015 - 06/2009
3Combination Drug Therapy (Combination Chemotherapy)
03/2015 - 04/2003
3Neoadjuvant Therapy
12/2013 - 01/2010
3Aftercare (After-Treatment)
11/2011 - 03/2006
3Radiotherapy
06/2009 - 01/2002
2Segmental Mastectomy (Lumpectomy)
11/2015 - 01/2010
2Therapeutics
01/2012 - 11/2008
1Intravenous Infusions
11/2015